HIGHLIGHTS
- who: Lehlogonolo N. F. Maphalle and collaborators from the Division of Pharmaceutical Sciences, School of Pharmacy, Sefako Makgatho Health Sciences University, Piscataway, NJ, USA have published the paper: Pediatric Tuberculosis Management: A Global Challenge or Breakthrough?, in the Journal: Children 2022, 9, 1120. of 17/06/2022
- what: The drugs used during the intensive treatment phase are mostly bactericidal in nature and work by rapidly killing ample amounts of the causative bacteria with the overall aim of preventing disease progression, infection transmission, and development of drug resistance. Although much progress has been made to improve . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.